IP Library Granted Patent US 10,537,604
Granted Patent B2
US 10,537,604 · App. 15/214,263 · Granted Jan 21, 2020

Compositions for enhancing brain activity

Inventors: Miguel Jimenez del Rio (Telde, ES); Julia C. Wiebe (Las Palmas de GC, ES); Laura Lopez-Rios (Las Palmas de GC, ES); Tanausu Vega-Morales (Las Palmas de GC, ES); Ruben Perez-Machin (Las Palmas de GC, ES); Alvaro Sanchez-Rodriguez (Las Palmas de GC, ES); Carlos Mateos (Las Palmas de GC, ES); Nigel Peter Gericke (Cape Town, ZA)
Assignee: NEKTIUM PHARMA, S.L.
A61K36/8905A61K31/352A61K31/522A61K31/7048A61K45/06A61P25/26
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,537,604
App. No.
15/214,263
Granted
Jan 21, 2020
Kind
B2
Abstract

A method for enhancing at least one of alertness, attention, concentration and memory in a person in need thereof, comprising administering a composition to said person, said composition comprising: a) an effective amount of an extract of Cyperus esculentus peel, Cyperus esculentus rhizomes, or a combination thereof; b) an effective amount of mangiferin, norathyriol, or an extract comprising mangiferin or norathyriol; or c) a synergistic combination of (a) and (b).

Claims (23)

1. A method for enhancing at least one of alertness, attention, concentration and memory in a person in need thereof, comprising administering a composition to said person, said composition comprising:

(a) an effective amount of an extract of Cyperus esculentus peel, Cyperus esculentus rhizomes, or a combination thereof; and

(b) an effective amount of mangiferin, norathyriol, or an extract comprising mangiferin or norathyriol;

wherein (a) and (b) have an effect on brain wave activity.

2. The method according to claim 1 , wherein said extract of Cyperus esculentus peel, Cyperus esculentus rhizomes, or a combination thereof is an aqueous extract, an alcoholic extract, a hydroalcoholic extract, or a supercritical CO 2 extract.

3. The method according to claim 1 , wherein (a) is a hydroalcoholic extract of Cyperus esculentus peel, and wherein the Cyperus esculentus peel is a Cyperus esculentus rhizome peel.

4. The method according to claim 1 , wherein said effective amount of said Cyperus esculentus peel, Cyperus esculentus rhizomes, or a combination thereof is between 20 mg and 20 g per dose.

5. The method according to claim 1 , wherein said effective amount of said mangiferin or said norathyriol is between 20 mg and 5 g per dose.

6. The method according to claim 1 , wherein said effective amount of said extract comprising mangiferin or norathyriol is sufficient to provide between 20 mg and 5 g mangiferin or norathyriol per dose.

7. The method according to claim 1 , wherein said extract comprising mangiferin or norathyriol is a mangiferin-containing extract of a plant species in a genus selected from the group consisting of Mangifera, Salacia, Cyclopia, Hypericum, Canscora, Fagraea, Gentiana, Hoppea, Swertia, Hypericum, Polygala, Zizyphus , and mixtures thereof.

8. The method according to claim 1 , wherein (b) comprises mangiferin or a mangiferin-containing extract of a plant species in a genus selected from the group consisting of Mangifera, Salacia, Cyclopia, Canscora, Fagraea, Gentiana, Hoppea, Coffea, Swertia, Hypericum, Polygala, Zizyphus , and mixtures thereof.

9. The method according to claim 8 , wherein (a) is an aqueous extract, an alcoholic extract, a hydroalcoholic extract, or a supercritical CO 2 extract of Cyperus esculentus peel, Cyperus esculentus rhizomes, or a combination thereof.

10. The method according to claim 9 , wherein (a) comprises a hydroalcoholic extract of Cyperus esculentus peel, wherein the Cyperus esculentus peel is a Cyperus esculentus rhizome peel.

11. The method according to claim 8 , wherein said effective amount of the extract of Cyperus esculentus peel, Cyperus esculentus rhizomes, or a combination thereof is between 20 mg and 20 g per dose; and said effective amount of said mangiferin or said mangiferin-containing extract is between 5 mg and 5 g per dose.

12. The method according to claim 1 , wherein the ratio of (a) to (b) is between about 1:1 and about 50:1.

13. The method according to claim 12 , wherein said composition is provided as a unit dose containing between 10 mg and 20 g per dose.

14. The method according to claim 12 , wherein the ratio of (a) to (b) is between about 1:1 and about 20:1.

15. The method according to claim 12 , wherein the ratio of (a) to (b) is between about 4:1 and about 15:1.

16. The method according to claim 1 , wherein said composition further comprises an active ingredient selected from the group consisting of B group vitamins, caffeine, citicoline, citrulline, choline, phosphatidylcholine, curcumin, huperzine, luteolin, ibogaine, magnesium, N-methyltyramine, omega-3 fatty acids, octopamine, phosphatidlyserine, phosphatidlyserine, quercetin, rutin, resveratrol, synephrine, taurine, taxifoline, theanine, theobromine, xanthohumol, yangonin, yohimbine, ecdysteroids (20HE) extracts of plant species of the genera Aloysia, Alpinia, Astragalus, Bacopa, Centella, Citrus, Coca, Cola, Curcuma, Coffea, Celastrus, Camellia, Eleutherococcus, Ephedra, Euterpe, Garcinia, Ginkgo, Ganoderma, Glycyrrhiza, Icarine, Ilex, Kaempferia, Ocimum, Paullinia, Panax, Pfaffia, Piper Pueraria, Rhodiola, Rhaponticum, Sida, Sideritis, Tabernanthe, Theobroma, Vitis, Withania, Zingiber, Zizyphus , and mixtures thereof.

17. The method of claim 1 , wherein said composition further comprises a caffeine-containing product.

18. A method for enhancing at least one of alertness, attention, concentration and memory in a subject in need thereof, comprising administering to said subject:

(a) a composition comprising an effective amount of an extract of Cyperus esculentus peel, Cyperus esculentus rhizomes, or a combination thereof; and

(b) a composition comprising an effective amount of mangiferin, norathyriol, or an extract comprising mangiferin or norathyriol; wherein composition (a) and composition (b) are administered in a ratio that increases gamma wave activity in the striatum and the frontal cortex of said subject, relative to administration of composition (a) or composition (b) individually; or decreasing alpha and beta-1 wave activity in the hippocampus of said subject, relative to administration of composition (a) or composition (b) individually.

Assignments (2)
CHANGE OF NAME Recorded Jul 10, 2019
From: POLIFENOLES NATURALES SL
To: NEKTIUM PHARMA, S.L.
Reel/Frame 049718/0492 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 19, 2016
From: DEL RIO, MIGUEL JIMENEZ; WIEBE, JULIA C.; LOPEZ-RIOS, LAURA; VEGA-MORALES, TANAUSU; PEREZ-MACHIN, RUBEN; SANCHEZ-RODRIGUEZ, ALVARO; MATEOS, CARLOS J.; GERICKE, NIGEL PETER
To: POLIFENOLES NATURALES, S.L.
Reel/Frame 039394/0237 →
Continuity (1)
Related Publication 20180021397A1 · Jan 25, 2018